Meet the ChemoCoat Board
Dr. Judit Puskás
Dr. Puskas is a recently retired Distinguished OSU Professor, Member of the NAE, Fellow of AIMBE, IUPAC and NAI, external member of the Hungarian Academy of Sciences and co-inventor of the polymer coating on the Taxus drug-eluting coronary stent, implanted in over 10 million people. She retired from OSU in 2026 to focus on clinical translation of her inventions within ChemoCoat. She is the winner of the 2017 Charles Goodyear Medal, the most prestigious award given by the Rubber Division of the American Chemical Society. Before her retirement, she was named The Inventor of the Year in 2026, College Distinguished Professor in January 2020, and OSU Distinguished Professor in 2024. She was elected to be a member of the National Academy of Engineering in 2023.
Chief Scientific Officer
Dr. Gábor Kaszás
Dr. Kaszas retired from the Goodyear Tire and Rubber Co. in 2016 where he served as Senior Associate Scientist at the Executive Level. Prior work includes Principal Scientist at LANXESS Inc. (formerly the Rubber Division of Bayer Inc., and Polysar Rubber Corp). He also has academic experience as a visiting scientist at the University of Akron (1980-81, 1986-88, 2016-18) and Adjunct Professor in the Department of Chemical and Biochemical Engineering, Faculty of Engineering, The University of Western Ontario, Canada (2000-2004). He was a visiting scientist at the Ohio State University during 2019-2026.
CEO & President
Borbala is NOT your father’s CPA. She is the person that entrepreneurial minded professionals and business owners call when they want stylish solutions to beat the IRS, legally! Borbala serves on the board of several non-profits and is passionate about helping women and minority owned start-ups get off the ground. She lives in Brecksville, Ohio with her husband, Attila, and their four teenagers. The family’s goal is to visit fifty countries and all seven continents.
Chief Financial OfficerBorbála Banto
Adam Kolozsvári
Adam Kolozsvari is a graduate with Honours of York University in Toronto. He has worked in the construction industry for over 20 years, with experience in all administrative aspects of running a construction business. In 2020, he branched out and started his own company, successfully growing it year over year. From coordinating jobs with both small and large-scale builders to collaborating with various trades and ensuring projects come in on-budget, Adam has built a varied skill set with strong leadership qualities and problem-solving capabilities. Adam can translate the needs and wants of conflicting voices to create a unified and target-oriented solution in high stress and time-sensitive environments, all while keeping everyone on the project at ease.
Chief Communications Officer
Anikó Kaszás
Aniko Kaszas is a graduate with Honours of the University of Toronto and has worked with several different companies as both a communications officer and marketing manager, designing websites, copywriting and editing technical documents, and coordinating grant applications, as well as developing external brand materials. A member of the Screen Actor’s Guild, she has produced several award-winning short films and documentaries and has acted as an adjudicator for select International Film Festivals, most recently as a judge for WIFF’s Mark Boscariol FlickFest. Aniko combines her unique skill for careful precision and compelling storytelling to help brands shape their image in an increasingly scrutinous public space.
Chief Administrative OfficerMeet the International Advisory Board
Dr. Domokos Máthé
Dr. Domokos Máthé is a senior research fellow at the Institute of Biophysics and Radiation Biology at Semmelweis University. For the past fifteen years, his research has focused on the gut-microbiome-brain axis and the use of multimodal molecular imaging to study the immune system. Dr Máthé develops targeted nanoparticles and new delivery systems for clinical isotope therapy of cancer. He has been the author of more than 260 scientific publications on immune, neuro and oncology topics and has served as a scientific consultant for a number of medical device and pharmaceutical companies.
Dr. László Forgács
Dr. László Forgách is a Research Associate at Semmelweis University, Department of Biophysics and Radiation Biology, and is affiliated with the HCEMM-SU In Vivo Imaging Advanced Core Facility. He holds a PharmD and a PhD in Pharmaceutical Sciences. His work focuses on molecular imaging, radiopharmacy, and nanomedicine, with experience in preclinical imaging, imaging agent development, nanoparticle-based systems, and translational biomedical research. He has worked in multidisciplinary academic and technology-oriented environments, with particular strengths in experimental design, standardized methodology, project execution, and scientific communication.
Dr. Fatemeh Heydari
Dr. Fatemeh Heydari is a Junior Researcher at Semmelweis University, Department of Biophysics and Radiation Biology, and is affiliated with the HCEMM-SU In Vivo Imaging Advanced Core Facility. She holds a PharmD, and her research focuses on nanotechnology, in vivo imaging, and pharmaceutical science, with particular emphasis on nanoparticle-based MRI contrast agents and imaging-related biomedical applications. Her work includes the development and evaluation of ferrite-based nanosystems, and she brings strong experience in laboratory research, data analysis, and scientific writing.
Enikö Krisch
Eniko Krisch is an Assistant Professor at Semmelweis University in Budapest, Hungary. She earned her BSc and MSc in Chemical Engineering, with a specialization in Pharmaceutical Sciences, and her PhD in Chemistry from the Budapest University of Technology and Economics. Her doctoral research focused on the synthesis and characterization of poly(amino acid)-based hydrogels and nanogels for drug delivery applications. After completing her PhD, she joined the Puskas Group at The Ohio State University to further develop her expertise in polymer chemistry and elastomer-based drug delivery systems. Following three years in the United States, she returned to Hungary and joined Semmelweis University, where she continues to collaborate with Dr. Puskas on the development of implant-based solutions for breast cancer patients. Her current research focuses on hydrogels and their biomedical applications.
Dr. Kristof Molnár
Dr. Molnar is an Associate Professor at Semmelweis (Medical) University in Budapest, Hungary. He holds a BSc and MSc in Chemical Engineering, specializing in Pharmaceutical Sciences, and a PhD in Theoretical Medicine. His doctoral research focused on the synthesis and characterization of hydrogel fiber-based soft implants. He joined the Puskas Group at The Ohio State University (USA) as a Post-doctoral Fellow (PDF) to expand his expertise in polymer chemistry and elastomer-based drug delivery systems. After three years in the United States, he returned to Semmelweis University, where he continues to collaborate with Dr. Puskas on developing implant-based solutions for cancer patients. His current research focuses on the development and investigation of nanofiber- and hydrogel-based soft medical implants.